Creative Planning’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $31M | Buy |
40,152
+10,018
| +33% | +$7.67M | 0.02% | 305 |
|
|
2025
Q4 | $23.3M | Buy |
30,134
+10,195
| +51% | +$6.92M | 0.02% | 330 |
|
|
2025
Q3 | $11.2M | Buy |
19,939
+10,454
| +110% | +$5.91M | 0.01% | 524 |
|
|
2025
Q2 | $4.98M | Sell |
9,485
-1,882
| -17% | -$1.05M | ﹤0.01% | 760 |
|
|
2025
Q1 | $7.21M | Buy |
11,367
+1,209
| +12% | +$832K | 0.01% | 590 |
|
|
2024
Q4 | $7.24M | Sell |
10,158
-1,635
| -14% | -$1.37M | 0.01% | 549 |
|
|
2024
Q3 | $12.4M | Buy |
11,793
+2,178
| +23% | +$2.42M | 0.01% | 382 |
|
|
2024
Q2 | $10.1M | Buy |
9,615
+991
| +11% | +$961K | 0.01% | 405 |
|
|
2024
Q1 | $8.3M | Buy |
8,624
+1,535
| +22% | +$1.46M | 0.01% | 459 |
|
|
2023
Q4 | $6.23M | Buy |
7,089
+421
| +6% | +$347K | 0.01% | 512 |
|
|
2023
Q3 | $5.49M | Buy |
6,668
+551
| +9% | +$433K | 0.01% | 501 |
|
|
2023
Q2 | $4.4M | Buy |
6,117
+350
| +6% | +$270K | 0.01% | 555 |
|
|
2023
Q1 | $4.74M | Buy |
5,767
+645
| +13% | +$486K | 0.01% | 523 |
|
|
2022
Q4 | $3.7M | Buy |
5,122
+731
| +17% | +$539K | 0.01% | 553 |
|
|
2022
Q3 | $3.02M | Buy |
4,391
+467
| +12% | +$294K | 0.01% | 562 |
|
|
2022
Q2 | $2.32M | Buy |
3,924
+1,225
| +45% | +$796K | ﹤0.01% | 669 |
|
|
2022
Q1 | $1.89M | Sell |
2,699
-25
| -0.9% | -$15.8K | ﹤0.01% | 740 |
|
|
2021
Q4 | $1.72M | Buy |
2,724
+270
| +11% | +$166K | ﹤0.01% | 735 |
|
|
2021
Q3 | $1.49M | Sell |
2,454
-535
| -18% | -$332K | ﹤0.01% | 778 |
|
|
2021
Q2 | $1.67M | Sell |
2,989
-3,317
| -53% | -$1.68M | ﹤0.01% | 739 |
|
|
2021
Q1 | $2.98M | Buy |
6,306
+1,401
| +29% | +$682K | 0.01% | 560 |
|
|
2020
Q4 | $2.37M | Buy |
4,905
+591
| +14% | +$319K | 0.01% | 603 |
|
|
2020
Q3 | $2.42M | Buy |
4,314
+605
| +16% | +$367K | 0.01% | 495 |
|
|
2020
Q2 | $2.31M | Sell |
3,709
-433
| -10% | -$246K | 0.01% | 453 |
|
|
2020
Q1 | $2.02M | Sell |
4,142
-1,489
| -26% | -$614K | 0.01% | 435 |
|
|
2019
Q4 | $2.11M | Sell |
5,631
-6,578
| -54% | -$2.21M | 0.01% | 497 |
|
|
2019
Q3 | $3.39M | Buy |
12,209
+201
| +2% | +$59.5K | 0.01% | 365 |
|
|
2019
Q2 | $3.76M | Buy |
12,008
+8,529
| +245% | +$2.84M | 0.01% | 342 |
|
|
2019
Q1 | $1.43M | Sell |
3,479
-49
| -1% | -$20.2K | 0.01% | 589 |
|
|
2018
Q4 | $1.32M | Sell |
3,528
-950
| -21% | -$348K | 0.01% | 559 |
|
|
2018
Q3 | $1.81M | Sell |
4,478
-5,917
| -57% | -$2.25M | 0.01% | 509 |
|
|
2018
Q2 | $3.59M | Buy |
10,395
+1,238
| +14% | +$387K | 0.01% | 332 |
|
|
2018
Q1 | $3.15M | Sell |
9,157
-1,639
| -15% | -$570K | 0.01% | 351 |
|
|
2017
Q4 | $4.06M | Sell |
10,796
-5,451
| -34% | -$2.21M | 0.02% | 287 |
|
|
2017
Q3 | $7.26M | Buy |
16,247
+2,542
| +19% | +$1.21M | 0.03% | 179 |
|
|
2017
Q2 | $6.73M | Sell |
13,705
-4,910
| -26% | -$2.15M | 0.03% | 183 |
|
|
2017
Q1 | $7.21M | Buy |
18,615
+2,596
| +16% | +$962K | 0.04% | 170 |
|
|
2016
Q4 | $5.88M | Sell |
16,019
-1,741
| -10% | -$662K | 0.04% | 189 |
|
|
2016
Q3 | $7.14M | Buy |
17,760
+3,026
| +21% | +$1.21M | 0.05% | 159 |
|
|
2016
Q2 | $5.15M | Buy |
14,734
+4,135
| +39% | +$1.59M | 0.04% | 167 |
|
|
2016
Q1 | $3.82M | Buy |
10,599
+7,992
| +307% | +$3.29M | 0.03% | 190 |
|
|
2015
Q4 | $1.42M | Sell |
2,607
-581
| -18% | -$315K | 0.01% | 396 |
|
|
2015
Q3 | $1.48M | Buy |
+3,188
| New | +$1.71M | 0.01% | 364 |
|
|
2015
Q2 | – | Sell |
-1,989
| Closed | -$898K | – | 2574 |
|
|
2015
Q1 | $898K | Sell |
1,989
-156
| -7% | -$66.1K | 0.01% | 505 |
|
|
2014
Q4 | $880K | Sell |
2,145
-341
| -14% | -$134K | 0.01% | 496 |
|
|
2014
Q3 | $896K | Buy |
2,486
+815
| +49% | +$273K | 0.01% | 437 |
|
|
2014
Q2 | $472K | Buy |
1,671
+236
| +16% | +$69.9K | 0.01% | 665 |
|
|
2014
Q1 | $431K | Buy |
1,435
+110
| +8% | +$33.9K | 0.01% | 689 |
|
|
2013
Q4 | $365K | Sell |
1,325
-61
| -4% | -$17.5K | 0.01% | 618 |
|
|
2013
Q3 | $434K | Buy |
1,386
+656
| +90% | +$173K | 0.01% | 486 |
|
|
2013
Q2 | $164K | Buy |
+730
| New | +$170K | ﹤0.01% | 748 |
|
Other funds holding REGN
VCM
N
Creative Planning's REGN Position: Q1 2026 in Review
Creative Planning increased its Regeneron Pharmaceuticals (REGN) stake by 33% in Q1 2026, buying an estimated $7.67M and bringing the position to 40,152 shares worth $31M. The position accounts for 0.02% of the portfolio, ranked #305.
Creative Planning first reported a position in REGN in Q2 2013 and has held it in 51 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Creative Planning held 40,152 shares of Regeneron Pharmaceuticals worth $31M as of Q1 2026.
- Creative Planning bought 10,018 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $7.67M.
- Regeneron Pharmaceuticals made up 0.02% of Creative Planning's portfolio in Q1 2026, its #305 holding.
- Creative Planning first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.